AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇼

LAMOTRIGINE in Zimbabwe

9 products registered with MCAZ — 9 active

Brand / ProductReg. No.HolderStatusExpires
LAMIGARD
TABLET; ORAL
2026/13.1/7468ORANGE HEALTH P/Lactive24 Jun 2031
LAMITOR-25
TABLET; ORAL
2005/13.1/4460TORRENT PHARMACEUTICALSactive17 Sept 2030
LAMITOR-50
TABLET; ORAL
2006/13.1/4461TORRENT PHARMACEUTICALSactive17 Jun 2030
LAMITOR DT 100
TABLET; ORAL
2025/13.1/6946TORRENT EXPORTS LTDactive8 May 2030
LAMITOR DT 50
TABLET; ORAL
2025/13.1/6945TORRENT EXPORTS LTDactive8 May 2030
LAMITOR DT 25
TABLET; ORAL
2025/13.1/6944TORRENT EXPORTS LTDactive8 May 2030
LAMODEP 50
TABLET; ORAL
2021/13.1/6176UNICHEM LABORATORIES LIMITEDactive31 Dec 2027
LAMODEP 100
TABLET; ORAL
2021/13.1/6177UNICHEM LABORATORIES LIMITEDactive31 Dec 2027
LAMODEP 25
TABLET; ORAL
2021/13.1/6175UNICHEM LABORATORIES LIMITEDactive31 Dec 2027

LAMOTRIGINE — MCAZ Registration Details

MCAZ (Zimbabwe) has 9 registered products containing LAMOTRIGINE, of which 9 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track LAMOTRIGINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.